Teva Sees Continued Legal Overhang As Q3 Sales Miss Mark

Firm Expects Branded Drugs To Drive Revenues Going Forward

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.